Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (87)

« Back to Publications

Addressing pandemic-wide systematic errors in the SARS-CoV-2 phylogeny

Hunt M. et al, (2026), Nature Methods, 23, 653 - 662

Micro-elimination of Hepatitis C virus (HCV) infection in the General Population Cohort in rural Uganda: Long-term follow-up to assess feasibility and outcomes of a screening and treatment intervention

Mugisha J. et al, (2026), Journal of Clinical Virology, 182, 105911 - 105911

Eligibility for hepatitis B virus (HBV) treatment and prevalence of drug resistance in a Ugandan population cohort

Lumley SF. et al, (2026), Journal of Infection, 92, 106682 - 106682

Micro-elimination of Hepatitis C virus (HCV) infection in the General Population Cohort in rural Uganda: long-term follow-up to assess feasibility and outcomes of a screening and treatment intervention

Mugisha J. et al, (2025)

Evaluation of Hepatitis B core-related antigen (HBcrAg) as a biomarker in cohorts from the United Kingdom and South Africa

Downs LO. et al, (2025), Journal of Infection, 91, 106601 - 106601

Is health, growth and development impaired in children who are Hepatitis B-exposed but uninfected?

Lumley SF. et al, (2025), PLOS Global Public Health, 5, e0004984 - e0004984

Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the field

Lumley SF. et al, (2025), The Lancet Microbe, 6, 101076 - 101076

A putative hepatitis B virus sequence motif associated with hepatocellular carcinoma in South African adults

Maponga TG. et al, (2025), Annals of Hepatology, 30, 101763 - 101763

Next-Generation Sequencing Methods for Sensitive Hepatitis B Viral Genome Analysis: A European Study

Fu MX. et al, (2025)

Eligibility for hepatitis B virus (HBV) treatment and prevalence of drug resistance in a Ugandan population cohort

Lumley SF. et al, (2025)

Whole genome sequencing of hepatitis B virus using tiled amplicon (HEPTILE) and probe based enrichment on Illumina and Nanopore platforms

Lumley SF. et al, (2025), Scientific Reports, 15

A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovir

Lumley SF. et al, (2024), Journal of Clinical Virology, 174, 105711 - 105711

Corrigendum to A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovir.

Lumley SF. et al, (2024), Journal of Clinical Virology, 174, 105716 - 105716

Whole genome sequencing of hepatitis B virus (HBV) using tiled amplicon (HEP-TILE) and probe-based enrichment on Illumina and Nanopore platforms

Lumley SF. et al, (2024)

Social, clinical and biological barriers to hepatitis B virus suppression with nucleos/tide analogue therapy: who is at risk and what should we do about it?

Im YR. et al, (2024), Sexually Transmitted Infections, 100, 259 - 263

Load More

1
2
3
4
5
6